LIFE aTyr Pharma, Inc. gains 85% Oct 16, 2017

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. The company develops Resolaris, which is in Phase Ib/II clinical trials for treating adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic myopathy with an immune component; patients with early onset FSHD; and adult patients with limb-girdle muscular dystrophy 2B or FSHD. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California. http://www.priceseries.com/trade/LIFE-aTyr-Pharma-Inc-stock-gains-85-percent-a-Trade-Record-by-priceSeries-2017091220171016.html